Hanmi Pharm. Co., Ltd. (KRX: 128940)

Hanmi Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	47,859	54,980	147,329	209,225	146,157	106,113
Short-Term Investments	40,985	109,736	89,408	2,510	1,874	1,979
Trading Asset Securities	158,046	90,466	-	-	-	-
Cash & Short-Term Investments	246,890	255,183	236,736	211,734	148,032	108,092
Cash Growth	10.72%	7.79%	11.81%	43.03%	36.95%	9.52%
Accounts Receivable	186,091	168,139	178,357	217,428	144,395	184,649
Other Receivables	642.36	9,079	1,703	5,180	4,825	5,442
Receivables	186,733	177,219	180,060	222,609	149,220	190,091
Inventory	291,136	288,814	266,185	250,189	308,538	326,727
Prepaid Expenses	2,789	865.96	4,595	10,511	739.04	28,220
Other Current Assets	11,766	8,543	6,581	8,466	7,844	9,074
Total Current Assets	739,313	730,624	694,158	703,509	614,373	662,204
Property, Plant & Equipment	841,870	860,242	917,982	957,218	1,000,040	999,512
Long-Term Investments	13,026	29,942	57,424	38,090	43,994	66,837
Other Intangible Assets	45,629	46,271	48,007	48,708	47,561	42,461
Long-Term Accounts Receivable	19,472	17,372	5,927	9,964	6,218	-
Long-Term Deferred Tax Assets	134,903	127,993	89,902	91,856	89,986	83,347
Long-Term Deferred Charges	39,648	34,774	36,580	31,461	25,325	23,783
Other Long-Term Assets	141,866	51,451	74,606	55,922	54,529	35,562
Total Assets	1,975,727	1,898,668	1,924,586	1,936,729	1,882,027	1,913,706
Accounts Payable	46,503	45,180	39,710	42,833	32,214	37,509
Accrued Expenses	18,554	16,660	14,389	11,103	11,364	8,797
Short-Term Debt	365,100	336,100	369,100	255,900	238,100	213,100
Current Portion of Long-Term Debt	77,514	145,351	80,364	144,125	161,723	83,786
Current Portion of Leases	2,587	2,325	3,043	55,141	1,945	1,733
Current Income Taxes Payable	14,551	6,088	10,677	13,463	611.44	742.2
Other Current Liabilities	153,310	153,059	159,465	126,373	87,493	126,136
Total Current Liabilities	678,120	704,763	676,748	648,938	533,451	471,803
Long-Term Debt	66,843	82,028	217,330	290,619	388,962	544,893
Long-Term Leases	6,872	7,063	8,486	10,481	11,457	8,055
Long-Term Deferred Tax Liabilities	-	-	-	-	452.18	1,571
Other Long-Term Liabilities	4,377	4,603	12,795	49,405	99,691	31,828
Total Liabilities	756,211	798,458	915,359	1,008,469	1,050,137	1,091,445
Common Stock	32,027	31,405	30,795	30,196	29,608	29,030
Additional Paid-In Capital	411,343	411,965	412,575	413,175	413,763	414,340
Retained Earnings	671,031	581,979	452,297	396,916	334,117	323,771
Treasury Stock	-43,327	-40,047	-36,976	-33,142	-28,268	-25,185
Comprensive Income & Other	-14,619	-29,860	13,174	-4,230	-19,231	-18,161
Total Common Equity	1,056,455	955,442	871,866	802,914	729,987	723,795
Minority Interest	163,060	144,768	137,361	125,346	101,902	98,466
Shareholders' Equity	1,219,515	1,100,211	1,009,227	928,259	831,889	822,261
Total Liabilities & Equity	1,975,727	1,898,668	1,924,586	1,936,729	1,882,027	1,913,706
Total Debt	518,916	572,867	678,323	756,267	802,187	851,567
Net Cash (Debt)	-272,027	-317,685	-441,586	-544,532	-654,156	-743,475
Net Cash Per Share	-21443.14	-25031.60	-34761.50	-42813.87	-51375.61	-58338.38
Filing Date Shares Outstanding	12.68	12.69	12.45	12.47	12.48	12.49
Total Common Shares Outstanding	12.68	12.69	12.7	12.72	12.73	12.74
Working Capital	61,193	25,861	17,410	54,571	80,922	190,401
Book Value Per Share	83315.27	75287.83	68636.66	63132.10	57333.59	56796.69
Tangible Book Value	1,010,827	909,172	823,858	754,205	682,427	681,334
Tangible Book Value Per Share	79716.85	71641.74	64857.35	59302.24	53598.14	53464.77
Land	131,788	131,788	131,280	131,256	129,166	126,234
Buildings	330,184	472,771	468,815	461,796	442,561	423,657
Machinery	339,593	838,165	837,205	792,572	738,355	478,985
Construction In Progress	13,008	14,815	6,206	69,731	111,646	346,450

Source: S&P Capital IQ. Standard template. Financial Sources.